Investor Home

Our History

We were founded in May 2012 in Leiden the Netherlands with the goal of developing a treatment for cystic fibrosis (CF). The founding team - Daniel de Boer, Gerard Platenburg, Dinko Valerio and Henri Termeer (28 February 1946 – 12 May 2017) - pulled together a team of motivated RNA and CF experts to work on a unique RNA therapy for CF. Our innovative and promising technolog  Read more

Share Performance

IR Contacts

Daniel de Boer
Chief Executive Officer
ProQR Therapeutics N.V.
Phone: +31 88 166 7000
E-mail: info@proqr.com
 
Bonnie Ortega
Director, Investor Relations
Phone: +1 858 245 3983
E-mail: ir@proqr.com

Media Contact

Sariette Witte
Director, Corporate Communications
Phone (NL): +31 6 2970 4513
Phone (US): +1 213 261 8891
E-mail: pr@proqr.com